Recent expert recommendations from the US and Europe endorse evaulating lipid levels in the nonfasting state.1,2 Among the reasons for the guidance are improved patient convenience and improved clinical efficiency: avoids overloading morning appointments for bloodwork. About 38% of patients in the US may already be having their lipids checked in the nonfasting state. Moreover, there are concerns about the accuracy of the standard formula used to assess LDL-C, the Friedewald Formula. A new study tests the Friedewald method against a new way to measure bad cholesterol. Click through this short slide show for details and results.